For example, FABP4+ LAMs release pro-inflammatory factors through lipolysis to suppress T cell function[24], and FABP6+ tumor cells downregulate MHC-I molecules to reduce T cell recognition[26], demonstrating the central role of FABPs in metabolic crosstalk between tumors and immune cells. The gene discussed is FABP6; the disease is neoplasm.